GH Research (GHRS) Change in Cash (2020 - 2025)
GH Research (GHRS) recorded quarterly Change in Cash of -$3.6 million in Q4 2025, up 10.24% quarter-over-quarter from -$4.0 million in Q3 2025, and down 132.87% on a YoY basis from $10.8 million in Q4 2024.
GH Research (GHRS) Change in Cash (2020 - 2025) Analysis & Trends
GH Research's Change in Cash history runs 6 years deep, the most recent figure standing at -$3.6 million for Q4 2025.
- In Q4 2025, Change in Cash fell 132.87% year-over-year to -$3.6 million; the TTM figure through Dec 2025 stood at $142.3 million (up 531.03% YoY), while the FY2025 annual figure was $142.3 million, up 531.03% from the prior year.
- Change in Cash was -$3.6 million for Q4 2025 at GH Research, up from -$4.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $288.0 million in Q2 2021 to a low of -$91.5 million in Q4 2022.
- Historically, Change in Cash has averaged $11.9 million across 5 years, with a median of -$4.0 million in 2021.
- The sharpest annual moves came in 2021 and 2025: Change in Cash tumbled 15309.09% in 2021, then jumped 16496.25% in 2025.
- A 5-year view of Change in Cash shows it stood at -$3.9 million in 2021, then slumped by 2217.78% to -$91.5 million in 2022, then jumped by 91.09% to -$8.2 million in 2023, then soared by 232.83% to $10.8 million in 2024, then slumped by 132.87% to -$3.6 million in 2025.
- The last three Change in Cash figures came in at -$3.6 million (Q4 2025), -$4.0 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -45.97 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | -3.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.56 Mn |
| Sep 30, 2025 | -3.96 Mn |
| Jun 30, 2025 | 5.67 Mn |
| Mar 31, 2025 | 144.12 Mn |
| Dec 31, 2024 | 10.83 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 9.68 Mn |
| Mar 31, 2024 | -879,000.00 |
| Dec 31, 2023 | -8.15 Mn |
| Sep 30, 2023 | -10.40 Mn |
| Jun 30, 2023 | -8.11 Mn |
| Mar 31, 2023 | -60.98 Mn |
| Dec 31, 2022 | -91.51 Mn |
| Sep 30, 2022 | -8.06 Mn |
| Jun 30, 2022 | -5.31 Mn |
| Mar 31, 2022 | -6.01 Mn |
| Dec 31, 2021 | -3.95 Mn |
| Sep 30, 2021 | -11.87 Mn |
| Jun 30, 2021 | 287.98 Mn |
| Mar 31, 2021 | -1.11 Mn |